Forte Biosciences, Inc.
FBRXNASDAQHealthcareBiotechnology
As of Aug 28, 2026 close
- Market cap
- $1.83B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $10.30$77.20
- Volume (live)
- -
- Avg. volume (3M)
- 1.82M
Forte Biosciences (FBRX) Stock Price & Financial Analysis
Forte Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $76.99 - $76.99 |
|---|---|
| 52-Week High | $77.20 |
| 52-Week Low | $10.30 |
| Open | $76.99 |
| Average Volume (3M) | 1.82M |
| 50-Day MA | $55.12 |
|---|---|
| 200-Day MA | $32.86 |
| 1-Year Change | +537.33% |
| Market Cap | 1.83B |
|---|---|
| Shares Outstanding | 23.79M |
| Price to Book (P/B) | 9.96 |
| EV/EBITDA | -18.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Aug 28, 2026. Data sources and methodology
Forte Biosciences at a Glance
As of the Aug 28, 2026 close, Forte Biosciences (FBRX) has a market capitalization of $1.83B.
As of its latest reported balance sheet, it holds $49.63M in cash and securities against $0.00 of debt, a net cash position of $49.63M.
Forte Biosciences does not currently pay a dividend.
The share price is up 537.3% over the past year. At $76.99 (the Aug 28, 2026 close) it sits near the top of its 52-week range of $10.30 to $77.20, above its 200-day moving average of $32.86.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $77.00, 0.00% above the Aug 28, 2026 close.
Frequently Asked Questions About Forte Biosciences
What is the current stock price for FBRX?
As of the Aug 28, 2026 close, FBRX stock trades at $76.99. The 52-week range is $10.30–$77.20, with a day range of $76.99–$76.99.
What is the P/E ratio for FBRX?
The P/E ratio (Price-to-Earnings) for FBRX is shown in the Key Statistics section. This valuation metric helps compare Forte Biosciences, Inc. to industry peers.
Does FBRX pay dividends?
Forte Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FBRX?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for FBRX is Hold. The average 12-month price target is $77.00, a 0.0% upside from the Aug 28, 2026 close of $76.99.
What is the market cap of FBRX?
As of the Aug 28, 2026 close, Forte Biosciences's market capitalization is $1.83B, classifying it as a small-cap company. Forte Biosciences operates in the Healthcare sector within the Biotechnology industry.